August 15th, 2023 on the presentation of JSC “National Holding “QazBioPharm” and accompanied by the head of the Marketing, Promotion and Export of products of the Holding Abdrakhmanov A.K., representatives of “Algimed Techno” LLP – Tremzina V.E., Paznyak A. and Zhakupova M.M visited the biopharm plant.
The purpose of the visit – to familiarize with the possibilities of the biofarm plant and discussion of cooperation issues.
Director General of the plant Yershebulov Z.D. acquainted the representatives of Algimed Techno LLP with the production unit, technological lines and quality control laboratories, and also told the history of formation, development and achievements of the plant.
According to the results of the visit, cooperation in the production of diagnostic test systems was planned.
On behalf of the Head of State, domestic scientists have developed a Kazakh vaccine against the coronavirus QazCovid-In, produced under the brand QazVac, which has shown high results and effectiveness in the fight against CVI.
The Head of State spoke about the effectiveness of the domestic vaccine against CVI in his Message to the people of Kazakhstan.
“The pandemic is still not receding all over the world. Every day thousands of our citizens get sick, many pass away. We immediately took measures to combat the pandemic, wasting no time. Kazakhstan is one of the few countries in the world that has developed a vaccine against coronavirus. There is no doubt that our vaccine is effective and safe. Now other countries are showing interest in QazVac,” the President of Kazakhstan said.
It is worth noting that vaccination is recognized worldwide as the only effective means of combating the COVID-19 pandemic. Only thanks to the vaccine, it is possible to form a collective immunity and return to the old doc-like rhythm of life. Scientists and doctors note that vaccinated people become infected with coronavirus much less often, and even in this case, the disease will proceed without severe complications and deaths. Given that the virus is constantly mutating, the sooner citizens are immunized, the more lives will be saved and the spread of the dangerous disease will be stopped.
The working trip of Kassym-Jomart Tokayev to Zhambyl region began with familiarization with the activities of the biopharmaceutical plant for the production of QazVac vaccines at the Research Institute of Biological Safety Problems, located in the village of Gvardeysky, Kordai district.
The President was shown a vaccine production line, laboratory equipment and mobile reactors.Director General of the Institute Kunsulu Zakaria reported on plans for further development of the Research Institute of Biological Safety Problems.
The plant will produce immunobiological medicines according to the international standard of good manufacturing practice (GMP), including a vaccine against coronavirus infection, vaccines against influenza, tuberculosis, brucellosis, nodular dermatitis and other infectious diseases.It is planned to produce from 30 to 60 million doses of biopharmaceuticals annually. The total cost of the project is 15.6 billion tenge.
Kassym-Jomart Tokayev was told that industrial bottling in the amount of 100 thousand doses was launched on September 16.Among the CIS countries, only Kazakhstan and Russia have established the production of vaccines against Covid-19.In an interview with the plant’s employees, the President of Kazakhstan, noting the importance of the project, expressed confidence that the domestic vaccine will make a significant contribution to the fight against coronavirus and strengthening public health.
On June 23, 2021, the Department for Registration and Land Cadastre of the branch of the non-profit Joint Stock Company “State Corporation “Government for Citizens” in the Zhambyl region” of the Kordai district registered the Limited Liability Partnership “OtarBioPharm”. The founder of which is the Republican State Enterprise on the right of economic management “Scientific Research Institute of Biological Safety Problems” of the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan.
The head of OtarBioPharm LLP was appointed Yershebulov Zakir
After launching and reaching full capacity, the OtarBioPharm Biopharmaceutical Plant will be the first large full-cycle plant in the Republic of Kazakhstan to produce immunobiological preparations (vaccines) against particularly dangerous infectious diseases according to the international standard of good manufacturing practice (GMP), including the QazVac coronavirus vaccine.
On December 16, 1991, the Constitutional Law “On State Independence of the Republic of Kazakhstan” was adopted by the Resolution of the Supreme Council of the Republic of Kazakhstan No. 1008-XII. The preamble of which states that the Supreme Council of the Republic of Kazakhstan, expressing the will of the people of Kazakhstan, recognizing the priority of individual rights and freedoms enshrined in the Universal Declaration of Human Rights and other universally recognized norms of international law, confirming the right of the Kazakh nation to self-determination, proceeding from the determination to create a civil society and a rule of law, implementing a peaceful foreign policy, declaring its commitment to the principle of non-proliferation of nuclear weapons and the disarmament process, solemnly proclaims the state independence of the Republic of Kazakhstan.
Over the years of independence, Kazakhstan has become a full member of the United Nations (UN), as well as a member of the Organization for Security and Co-operation in Europe (OSCE), the Shanghai Cooperation Organization (SCO), the Commonwealth of Independent States (CIS), the Eurasian Economic Union (EAEU), the Collective Security Treaty Organization (CSTO) and other organizations.